Merck KGaA Profit Beats Estimates on Cost-Cutting

May 14 (Bloomberg) -- Merck KGaA, the German maker of cancer drug Erbitux, said first-quarter profit rose on higher-than-expected savings from a reorganization program, and forecast it will achieve 2014 targets a year ahead of schedule. Mark Barton reports on Bloomberg Television's "Countdown." (Source: Bloomberg)
China Banks to Have 'Negative' Growth: Mizuho's Antos
45:29 - Jim Antos, an analyst at Mizuho Securities Asia Ltd. in Hong Kong, talks about China's banks. China Construction Bank Corp. joined the club of big Chinese banks reporting zero profit growth and rising bad loans as the government struggles to prop up the economy. Antos speaks with Rishaad Salamat on Bloomberg Television's "Trending Business." (Source: Bloomberg)
  • Investing In Asia's Future Female Leaders
  • Why Investors Say Malaysia Is Still a Good Option
  • China Slowing Has Less Effect on India: Rajan